Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010232
Filing Date
2017-05-10
Accepted
2017-05-10 16:06:47
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi-10q_20170331.htm 10-Q 1236787
2 EX-31.1 pbyi-ex311_7.htm EX-31.1 11921
3 EX-31.2 pbyi-ex312_10.htm EX-31.2 11939
4 EX-32.1 pbyi-ex321_8.htm EX-32.1 8883
5 EX-32.2 pbyi-ex322_6.htm EX-32.2 9020
  Complete submission text file 0001564590-17-010232.txt   5240002

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pbyi-20170331.xml EX-101.INS 1324642
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20170331.xsd EX-101.SCH 32215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20170331_cal.xml EX-101.CAL 33866
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20170331_def.xml EX-101.DEF 90637
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20170331_lab.xml EX-101.LAB 287732
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20170331_pre.xml EX-101.PRE 213166
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 17830245
SIC: 2834 Pharmaceutical Preparations